Suppr超能文献

含吡罗昔康的半固体分散体在硬明胶胶囊中的物理稳定性评估与增强

Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.

作者信息

Karataş Ayşegül, Bekmezci Serife

机构信息

Department of Pharmaceutical Technology, School of Pharmacy, Ankara University, 06100-Tandoğan, Ankara, Turkey.

出版信息

Acta Pol Pharm. 2013 Sep-Oct;70(5):883-97.

Abstract

The aim of the study was to investigate the physical stability of the semi-solid dispersions into the hard gelatine capsules prepared with Gelucire 44/14, Labrasol and different additives such as microcrystalline cellulose (MCC), mannitol and lactose (alpha-monohydrate) used for enhancing the stability of the formulations. The master dispersion prepared with only Gelucire 44/14 (20% w/w) and Labrasol (80% w/w) was stored in a refrigerator (5 +/- 3 degrees C), while the modified dispersions with the additives (2% w/w) were kept in a climatic chamber (25 +/- 2 degrees C / 60 +/- 5% RH) for 12 months. Dissolution tests of the semi-solid dispersions were performed in media with different pH's immediatly after preparation and after 3, 6 and 12 months of storage. FTIR and DSC studies were also carried out at the same time points. The ideal storage condition for the master dispersion was found to be at 5 degrees C. The addition of MCC, mannitol and lactose (alpha-monohydrate) to the original dispersion afforded a solidification effect on the formulation at room temperature and showed the same dissolution behavior (not less than 85% of piroxicam within 30 min in pH 1.2, 4.5 and 6.8; and water) with the master. The dispersion including lactose was stable at 25 degrees C for 12 months. However, the ideal period of storage for the modified dispersions including MCC and mannitol was 6 months at 25 degrees C. FTIR and DSC results both confirmed the amorphous state of piroxicam in all semi-solid dispersions under storage conditions for 12 months.

摘要

本研究的目的是考察半固体分散体在由Gelucire 44/14、Labrasol和不同添加剂(如微晶纤维素(MCC)、甘露醇和乳糖(α-一水合物))制备的硬明胶胶囊中的物理稳定性,这些添加剂用于提高制剂的稳定性。仅用Gelucire 44/14(20% w/w)和Labrasol(80% w/w)制备的主分散体储存在冰箱(5±3℃)中,而含有添加剂(2% w/w)的改良分散体在气候箱(25±2℃/60±5% RH)中保存12个月。半固体分散体的溶出度试验在制备后以及储存3、6和12个月后在不同pH值的介质中进行。同时还进行了傅里叶变换红外光谱(FTIR)和差示扫描量热法(DSC)研究。发现主分散体的理想储存条件为5℃。在原始分散体中添加MCC、甘露醇和乳糖(α-一水合物)在室温下对制剂产生固化作用,并且与主分散体表现出相同的溶出行为(在pH 1.2、4.5和6.8以及水中30分钟内吡罗昔康溶出不少于85%)。含乳糖的分散体在25℃下稳定12个月。然而,含MCC和甘露醇的改良分散体在25℃下的理想储存期为6个月。FTIR和DSC结果均证实了在储存12个月的条件下所有半固体分散体中吡罗昔康的无定形状态。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验